Gritstone bio Reports First Quarter 2024 Financial Results and ...

Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates · In April 2024 , Gritstone completed an underwritten ...

Gritstone bio to Report First Quarter 2024 Financial Results and ...

(Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced it will report ...

Gritstone bio Reports First Quarter 2024 Financial Results

EMERYVILLE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to ...

Press Releases - Gritstone bio

Gritstone bio to report first quarter 2024 financial results and provide corporate updates on May 9, 2024.

Gritstone bio Q1 2024 Financial Results & Corporate Updates

Gritstone bio, Inc. has announced its financial outcomes for the first quarter ending March 31, 2024, along with updates on its corporate ...

Gritstone bio to Report First Quarter 2024 Financial - GlobeNewswire

(Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world's most potent vaccines, today announced it will report ...

Gritstone Oncology Reports First Quarter Financial Results and ...

Gritstone Oncology Reports First Quarter Financial Results and Recent Highlights ; Collaboration revenue was $1.3 million for the three months ended · $1.3 ...

Gritstone bio Reports First Quarter 2024 Financial Results and ...

Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates ... Information presented is provided 'as-is' and solely ...

First Quarter 2024 Financial Results and Provide Corporate Updates

... Reports · Corporate Governance · SEC Filings ... Gritstone Bio |. Footer Links. Privacy Policy · Terms of Use · Cookie Policy · Contact. socials.

Form 8-K for Gritstone BIO INC filed 05/09/2024

Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates. -- Favorable progression-free survival (PFS) trend ...

Gritstone bio Reports Second Quarter 2024 Financial Results and ...

The company's cash position improved to $61.7 million , up from $52.8 million in Q1, bolstered by a $32.5 million public offering. However ...

Press Releases | Gritstone bio

Gritstone Oncology Reports Second Quarter Financial Results and Recent Highlights · Gritstone Oncology to Present at Two Upcoming Investor Conferences in August.

GRTS Q1-2024 Earnings Call - Alpha Spread

Turning now to our Q1 2024 operating results. We reported a net loss of $40.4 million compared with $34 million for the same period last year. The increase in ...

BioNTech Announces First Quarter 2024 Financial Results and ...

Research and development (“R&D”) expenses were €507.5 million for the three months ended March 31, 2024, compared to €334.0 million for the comparative prior ...

Gritstone bio (@gritstonebio) / X

We will report our first quarter 2024 earnings after market close on Thursday, May 9, 2024, followed by a conference call and audio webcast, which will begin at ...

Gritstone bio, Inc. (GRTS) Interactive Stock Chart - Yahoo Finance

Gritstone bio Reports First Quarter 2024 Financial Results and Provides Corporate Updates. GlobeNewswire • 5 months ago ...

Gritstone bio Reports First Quarter 2024 Financial Results ... - LinkedIn

Today, we reported our first quarter 2024 financial results and shared corporate and clinical updates. We will be hosting a conference call and audio ...

Gritstone bio Reports Second Quarter 2024 Financial Results and ...

Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates · In April 2024 , Gritstone completed an underwritten ...

Day One Reports First Quarter 2024 Financial Results and ...

Net Loss: Net loss totaled $62.4 million for the first quarter of 2024 with non-cash stock compensation expense of $12.6 million, compared to $42.4 million for ...

GRTS - Gritstone bio, Inc. Latest Stock News & Market Updates

(Nasdaq: GRTS) will report its first-quarter 2024 financial results and provide corporate updates on May 9, 2024. The company, a clinical-stage biotechnology ...